Cargando…
Small Molecule Epigenetic Modulators in Pure Chemical Cell Fate Conversion
Although innovative technologies for somatic cell reprogramming and transdifferentiation provide new strategies for the research of translational medicine, including disease modeling, drug screening, artificial organ development, and cell therapy, recipient safety remains a concern due to the use of...
Autores principales: | Yuan, Zhao-Di, Zhu, Wei-Ning, Liu, Ke-Zhi, Huang, Zhan-Peng, Han, Yan-Chuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596432/ https://www.ncbi.nlm.nih.gov/pubmed/33144865 http://dx.doi.org/10.1155/2020/8890917 |
Ejemplares similares
-
Reprogramming cell fates by small molecules
por: Ma, Xiaojie, et al.
Publicado: (2017) -
Modulation of protein fate decision by small molecules: targeting molecular chaperone machinery
por: Wang, Lei, et al.
Publicado: (2020) -
Insights on Carbon
Neutrality by Photocatalytic Conversion
of Small Molecules into Value-Added Chemicals or Fuels
por: Jiao, Haimiao, et al.
Publicado: (2022) -
Small molecules for mesenchymal stem cell fate determination
por: Cheng, Yu-Hao, et al.
Publicado: (2019) -
SUV39H2 epigenetic silencing controls fate conversion of epidermal stem and progenitor cells
por: Balmer, Pierre, et al.
Publicado: (2021)